<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00480675</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00006986</org_study_id>
    <nct_id>NCT00480675</nct_id>
  </id_info>
  <brief_title>Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of our research project are to study the relationship, if any, between the success&#xD;
      of a TB injection (measured by pain relief and general patient satisfaction) and the method&#xD;
      in which it was placed. Because fluoroscopy places patients requires a slight risk from&#xD;
      radiation exposure and increased cost versus blind injection, it is important to know if&#xD;
      there is an advantage to using this technique. The investigators will randomize 64 patients&#xD;
      to receive either trochanteric bursa injections with corticosteroid and local anesthetic&#xD;
      guided by fluoroscopy, or trochanteric bursa patients to receive trochanteric bursa&#xD;
      injections based on landmarks on palpation. The investigators will then determine which&#xD;
      method is superior, and whether injecting steroid and local anesthetic into the bursa itself&#xD;
      is superior or inferior to injecting it into a tender area outside the bursa.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a randomized, controlled study evaluating the value of fluoroscopy in&#xD;
      trochanteric bursa injections. Subjects will be recruited solely from the patients we&#xD;
      normally see at the Blaustein Pain Treatment Center with a clinical diagnosis of GTPS.&#xD;
      Sixty-four patients will be randomized in a 1:1 ratio using sealed envelopes to receive&#xD;
      either TB corticosteroid injection done blind or with fluoroscopy. All patients who provide&#xD;
      informed consent will be brought into the fluoroscopy suite and placed in the lateral&#xD;
      decubitus position. In the patients randomized to receive fluoroscopically guided injections,&#xD;
      a 22-gauge needle will be placed into the TB and correct position confirmed by fluoroscopy&#xD;
      and contrast injection (1 ml per attempt) before corticosteroid and local anesthetic&#xD;
      injection (60 mg of depomedrol and 2.5 ml of 0.5% bupivacaine). In the blinded group, one&#xD;
      sham, pulsed fluoroscopic image will be taken of the femur, and the injection will be done&#xD;
      based only on physical exam (overlying the area of maximal tenderness) and landmarks. Prior&#xD;
      to the injection, 1 ml of contrast will be administered and another image taken to determine&#xD;
      whether or not the needle is within the bursa, but this will not alter the injection. After&#xD;
      contrast administration, the same corticosteroid and bupivacaine injection will be&#xD;
      administered. The 2 main questions we propose to answer are: 1) whether using fluoroscopy for&#xD;
      TB injections results in improved outcomes (comparison of the 32 patients in each group); and&#xD;
      2) whether injecting into the bursa provides superior results than performing non-bursal&#xD;
      injections into the area of maximal tenderness (comparison of 32 patients who receive&#xD;
      fluoroscopically-guided bursa injections + those patients whose blinded injection was noted&#xD;
      to be intra-bursal vs. those patients whose blinded injection was extra-bursal).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical pain scores</measure>
    <time_frame>1 and 3 month post-injection</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-36, Oswestry Disability Index, Satisfaction</measure>
    <time_frame>1 and 3 months post-injection</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Bursitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trochanteric bursa injections done into the bursa under fluoroscopic guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trochanteric bursa injection done with sham fluoroscopy using only landmarks as guidance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trochanteric bursa injection done under fluoroscopy with depomedrol and bupivacaine</intervention_name>
    <description>Depomedrol 60 mg + bupivacaine 2.5 ml</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trochanteric bursa injection with depomedrol and bupivacaine</intervention_name>
    <description>Trochanteric bursa injection done with sham x-ray and 60 mg of depomedroal and 2.5 ml bupivacaine using landmarks for guidance.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Clinical diagnosis of trochanteric bursitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Allergy to contrast&#xD;
&#xD;
          -  Untreated coagulopathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven P Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blaustein Pain Treatment Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cohen SP, Narvaez JC, Lebovits AH, Stojanovic MP. Corticosteroid injections for trochanteric bursitis: is fluoroscopy necessary? A pilot study. Br J Anaesth. 2005 Jan;94(1):100-6. Epub 2004 Oct 29.</citation>
    <PMID>15516348</PMID>
  </reference>
  <reference>
    <citation>Schapira D, Nahir M, Scharf Y. Trochanteric bursitis: a common clinical problem. Arch Phys Med Rehabil. 1986 Nov;67(11):815-7.</citation>
    <PMID>3778178</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <study_first_submitted>May 30, 2007</study_first_submitted>
  <study_first_submitted_qc>May 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2007</study_first_posted>
  <last_update_submitted>January 27, 2009</last_update_submitted>
  <last_update_submitted_qc>January 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Johns Hopkins Office of Research Administration</name_title>
    <organization>Amanda Gibson</organization>
  </responsible_party>
  <keyword>bursitis</keyword>
  <keyword>injection</keyword>
  <keyword>fluoroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

